Navigation Links
Can hantavirus infection spread among humans?
Date:1/18/2008

Ume findings raise the question: Can hantavirus infection spread among humans?

In connection with last year's epidemic, a research team at Ume University in Sweden has managed for the first time to show that hantavirus exists in human saliva. This raises the question of whether this contagion can spread among humans.

In Sweden, a form of hemorrhagic fever with renal syndrome called nephropathia epidemica occurs primarily in the northern parts of the country. It is a zoonosis, that is, an infectious disease that is normally transmitted between animals and humans when a bank vole, for instance, releases Puumala hantavirus via its saliva, urine, and feces. Normally humans become infected by breathing in dust polluted by virus from bank vole secretions or by direct contact with the animal.

It has recently been shown in South America that the Andes hantavirus, which is closely related to the Puumala hantavirus, can in some cases be transmitted among humans. The Ume team's findings indicate that a possible path of contagion for hantavirus disease might be human saliva. During last year's outbreak of nephropathia epidemica in northern Sweden, saliva samples were collected from 14 patients in Vsterbotten County, and virus RNA was found in the saliva in ten cases. It is not clear whether the virus found in human saliva is capable of infecting another human, but this question is now being studied intensively.

Nephropathia epidemica, is a serious disease, and patients coming to hospitals often have high fevers, headaches, muscle pain, and abdominal pain, and are in generally poor condition. In Sweden some 2,200 cases of nephropathia epidemica were reported in 2007, and more than 800 of them were from Vsterbotten County. Up to 30% of those who were diagnosed with nephropathia epidemica wind up in the hospital, and in Vsterbotten County two deaths occurred in 2007. In South and North America infections by close relatives of the P
'/>"/>

Contact: Hans Fallman
hans.fallman@adm.umu.se
46-706-912-829
Swedish Research Council
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Toxoplasma infection increases risk of schizophrenia, study suggests
2. Attention: Extra-hepatic manifestation of hepatitis C virus infection
3. Study Spotlights a Natural Infection Fighter
4. Catheter chaos: Hospitals lag in preventing common infection
5. Making hospitals safer from infection
6. Simple strategy could prevent half of deadly tuberculosis infections
7. APIC launches Targeting Zero initiative to eradicate infections deemed preventable by CMS
8. Advertisements for Medical Devices, Implants Should Carry Warnings of Dangerous Side Effects, Infections
9. CDC Uses New Technical Approach to Enable Hospital Reporting of Healthcare-Associated Infections
10. 31 Million Americans Suffer From Sinus Infections
11. Poll of Infection Prevention and Control Professionals Reveals MRSA Prevention Progress Six Months After National Survey
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine News(10 mins):Health News:Mike Lucas of GE Healthcare Recognized as the Lifeline for Minority Businesses; Receives the MMBDC 2009 President's Award 2Health News:The Kenneth Rainin Foundation Awards $457,000 in Grants to Support Dance, Theater, Film and Early Literacy in the San Francisco Bay Area 2Health News:The Kenneth Rainin Foundation Awards $457,000 in Grants to Support Dance, Theater, Film and Early Literacy in the San Francisco Bay Area 3Health News:Webmedx Announces #1 Ranking in KLAS 2009 Transcription Services Report 2Health News:Webmedx Announces #1 Ranking in KLAS 2009 Transcription Services Report 3Health News:Astronaut Balancing Act: Training to Help Explorers Adapt to a Return to Gravity 2Health News:Astronaut Balancing Act: Training to Help Explorers Adapt to a Return to Gravity 3Health News:Astronaut Balancing Act: Training to Help Explorers Adapt to a Return to Gravity 4Health News:Nerve-cell transplants help brain-damaged rats fully recover lost ability to learn 2Health News:Nerve-cell transplants help brain-damaged rats fully recover lost ability to learn 3
Breaking Medicine Technology:TNF-Alpha Inhibitors Are Being Used More Often To Treat Newly Diagnosed Patients With Crohn's Disease 2TNF-Alpha Inhibitors Are Being Used More Often To Treat Newly Diagnosed Patients With Crohn's Disease 3Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 2Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 3Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 4Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 5Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 6Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 7Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 8Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 9Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 10Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 11Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 12Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 13Roper Industries Completes the Acquisition of Verathon, Inc. 2Roper Industries Completes the Acquisition of Verathon, Inc. 3delSECUR CORPORATION Announces Agreement to Purchase the Intellectual Property Assets of the Corporation 9666 1delSECUR CORPORATION Announces Agreement to Purchase the Intellectual Property Assets of the Corporation 9666 2Advances in lung cancer research announced at conference 55064 1Advances in lung cancer research announced at conference 55064 2Fecal DNA methylation detects gastric and colorectal cancers 55060 1Fecal DNA methylation detects gastric and colorectal cancers 55060 2
Other Medicine Technology:Medivation's Dimebon Maintains Statistically Significant Benefit on,All Five Efficacy Endpoints in Alzheimer's Disease Trial After One,Year of Therapy 2Medivation's Dimebon Maintains Statistically Significant Benefit on,All Five Efficacy Endpoints in Alzheimer's Disease Trial After One,Year of Therapy 3Medivation's Dimebon Maintains Statistically Significant Benefit on,All Five Efficacy Endpoints in Alzheimer's Disease Trial After One,Year of Therapy 4Medivation's Dimebon Maintains Statistically Significant Benefit on,All Five Efficacy Endpoints in Alzheimer's Disease Trial After One,Year of Therapy 5Medivation's Dimebon Maintains Statistically Significant Benefit on,All Five Efficacy Endpoints in Alzheimer's Disease Trial After One,Year of Therapy 6Pilot Phase 3 Results of NovaCardia's KW-3902 for Acute Congestive,Heart Failure Presented at Late-Breaking Session of Heart Failure,Congress 2007 2Pilot Phase 3 Results of NovaCardia's KW-3902 for Acute Congestive,Heart Failure Presented at Late-Breaking Session of Heart Failure,Congress 2007 3Pilot Phase 3 Results of NovaCardia's KW-3902 for Acute Congestive,Heart Failure Presented at Late-Breaking Session of Heart Failure,Congress 2007 4